Negative pressure wound therapy
DeviceApplication of a negative wound pressure therapy dressing to the wound post laparotomy
NCT Number: NCT06647290
This is a single-blinded, multicentre, prospective randomised controlled trial (RCT) comparing post-operative and patient-reported outcomes for patients undergoing application of negative-pressure wound therapy (NPWT) after sinus tract excision as compared to excision and standard open wound care in chronic pilonidal sinus disease (PSD).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Beaumont Hospital, Dublin, Ireland
Pilonidal sinus disease (PSD) is a chronic inflammatory condition of the skin and subcutaneous tissues arising from hair follicles in the natal cleft. The definitive aetiology of the condition is unknown, however, it is theorised that it is the result of either the obstruction and subsequent inflammation of hair follicles or secondary to hair penetrating through the skin into the subcutaneous tissue. This results in infection, abscess formation, chronic discharge and pain. PSD is a common condition affecting 26 per 10,000 population, with the prevalence reaching 1.1% in young adult males.
PSD causes a significant burden on healthcare services due to high rates of recurrence and readmission following surgery, together with negative impacts on patients' quality of life and self-image. An effective management strategy for the disease is necessary to ensure that post-operative outcomes are optimised and patient-reported outcomes are satisfactory in those whose PSD requires surgery.
The objective of this multicentre, national RCT is to prospectively investigate the effect of negative pressure wound therapy compared to leaving open with standard wound care on time to wound healing following surgical excision of chronic PSD.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
i) They are aged 18 years or older
ii) They are undergoing elective pilonidal sinus excision without primary closure
Exclusion criteria
i) They are unable to adhere to protocol requirements e.g. questionnaire completion
ii) They are undergoing emergency drainage for a pilonidal abscess
iii) They are undergoing surgery for a pilonidal sinus disease in locations other than the natal cleft
iv) They have underlying osteomyelitis
v) They have underlying fistulating disease e.g. Crohn's
Application of a negative wound pressure therapy dressing to the wound post laparotomy
Time frame: 6 months post surgery
Number of days to complete epithelialisation or closure of the wound without any discharge, drainage, scab, and/or the requirement for further dressing. The quality of wound healing will be assessed using a validated patient and observer reported scar assessment tool-POSAS.
Time frame: 6 months post surgery
Pain measured by visual analogue pain scores which is a scale from 1 (no pain) to 10 (worst pain), between the NPWT and SWC Groups.
Time frame: 6 months post surgery
Measure of post operative complications between the NPWT and SWC Groups
Time frame: 6 months post surgery
To compare quality-of-life differences between the two groups from the time of surgery until wound healing is achieved using the
Time frame: 6 months post surgery
To investigate resource use and thereby cost effectiveness of NPWT versus standard wound care
Time frame: 6 months post surgery
To compare the 6-month recurrence rates (recurrence being defined as the development of a new sinus or abscess within the natal cleft occurring after wound healing had been achieved) between the NPWT and SWC Groups
Time frame: 1 month
The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)
Time frame: 3 months
The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)
Time frame: 6 months
The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)
Time frame: 1 month
The POSAS is made up of two scales: the patient scale and the observer scale; each of the six components is scored numerically on a scale of 1 to 10. The component scores are then added together; the worst scar would receive a score of 60, while the best scar would receive a score of 6
Time frame: 3 months
The POSAS is made up of two scales: the patient scale and the observer scale; each of the six components is scored numerically on a scale of 1 to 10. The component scores are then added together; the worst scar would receive a score of 60, while the best scar would receive a score of 6
Time frame: 6 months
The POSAS is made up of two scales: the patient scale and the observer scale; each of the six components is scored numerically on a scale of 1 to 10. The component scores are then added together; the worst scar would receive a score of 60, while the best scar would receive a score of 6
Time frame: 1 Month
The CoPaQ measures patient and caregivers out-of-pocket expenses (direct and indirect) associated with a health condition
Time frame: 3 Months
The CoPaQ measures patient and caregivers out-of-pocket expenses (direct and indirect) associated with a health condition
Time frame: 6 Months
The CoPaQ measures patient and caregivers out-of-pocket expenses (direct and indirect) associated with a health condition
Time frame: 6 Months
Investigating resource use and cost effectiveness of single-use, prophylactic negative pressure wound therapy versus standard dressings for midline laparotomy wounds based on length of hospital stay and costs of dressings
Time frame: Day of Surgery
Measurement of pain intensity
Time frame: 1 Month
Measurement of pain intensity
Time frame: 3 Months
Measurement of pain intensity
Contact information is provided by the study sponsor or research team.
Eanna Ryan
CONTACT
Sean T Martin
CONTACT
Royal College of Surgeons, Ireland
Other
Excision and Negative Pressure Wound Therapy Versus Excision and Leaving Open With Standard Wound Care for Management of Chronic Pilonidal Sinus Disease - A Randomised Controlled Trial
Acronym: ENVELOP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07534488
Cysts, Neoplasms
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05243966
Abdominal Wound Dehiscence, Anal Fistula
Phoenix, Arizona, United States
View Trial DetailsNCT07369921
Cysts, Neoplasms
Istanbul, Umraniye, Turkey (Türkiye)
View Trial DetailsNCT07314632
Cysts, Neoplasms
Cornebarrieu, France
View Trial Details